Skip to main content

Table 2 CCK8 assay on MCF-7 cells and MCF-7/ADR cells

From: LncRNA CBR3-AS1 regulates of breast cancer drug sensitivity as a competing endogenous RNA through the JNK1/MEK4-mediated MAPK signal pathway

medicine

IC50 (μM) ± SD

MCF-7

MCF-7/OE-CBR3-AS1

MCF-7/ADR

MCF-7/ADR-si-CBR3-AS1-1

MCF-7/ADR-si-CBR3-AS1-2

ADR

0.11±0.02

0.28±0.05

30.16±3.13

8.54±2.65

10.37±1.94